BioCentury
ARTICLE | Company News

Silence Therapeutics management update

December 22, 2014 8:00 AM UTC

Silence Therapeutics plc (LSE:SLN), London, U.K. Business: Cancer, Renal, Ophthalmic Hired: Lars Karlsson as head of R&D and a director, effective Jan. 5, 2015, formerly VP of autoimmune disease pharm...